Printer Friendly
The Free Library
19,607,053 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Enzon Announces Conference Call Regarding Formation of Broad Strategic Alliance With Inhale.


Business & Health Editors

PISCATAWAY, N.J.--(BUSINESS WIRE)--Jan. 7, 2002

Enzon, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: ENZN) announced today that company management are hosting a conference call on Tuesday, January 8, 2002 at 8:00AM EST EST electroshock therapy.

EST
abbr.
electroshock therapy
 regarding the formation of a broad strategic alliance with Inhale in·hale
v.
1. To breathe in; inspire.

2. To draw something such as smoke or a medicinal mist into the lungs by breathing; inspire.
 Therapeutics therapeutics

Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry.
, Inc. (NASDAQ: INHL INHL Institute for Nursing Healthcare Leadership ).

All interested parties may access the call by using the following information:

                Domestic Dial-In Number:           888-276-9995
                International Dial-In Number:      612-288-0337
                Access Code                        622399


The call will also be webcast in a "listen only" mode via the internet at http://www.vcall.com. Additionally, for those parties unable to listen at the time of the call, a rebroadcast will be available following the call from Tuesday, January 8, 2002 at approximately 1:15PM. This rebroadcast will end on Tuesday, January 15, 2002 at 11:59PM. The rebroadcast may be accessed using the following information:


               Domestic Dial-In Number:           800-475-6701
               International Dial-In Number:      320-365-3844
               Access Code                        622399


This release is also available at http://www.enzon.com
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 7, 2002
Words:162
Previous Article:SilverStream Software, Inc. Announces Preliminary Fourth Quarter and Fiscal Year End 2001 Results; Conference Call Scheduled For February 13, 2002 at...
Next Article:OSHA 300 Recordkeeping Course Now Available Online Through PureSafety.
Topics:



Related Articles
Enzon Initiates Phase II Clinical Trial for PROTHECAN.
Enzon Announces Schering-Plough In-Licensing Agreement With Roche Resolving Peginterferon Patent Disputes.
Enzon and Inhale Announce Formation of Broad Strategic Alliance.
Inhale Announces Fourth Quarter and Year Ended 2001 Financial Results.
Enzon Reports Four-Fold Increase in Second Quarter Earnings.
Enzon Announces Inhale PEGylation Agreements.
Enzon and Micromet Announce Strategic Collaboration for Novel Single-Chain Antibody Therapeutics.
Enzon And Micromet To Host Technology Briefing On Single-Chain Antibody Collaboration.
Enzon Reports 121% Increase in Third Quarter Earnings; PEG-INTRON Royalties Continue to Drive Earnings.
ENZON/INEX SIGN COMMERCIALIZATION PACT FOR ONCOLOGY DRUG ONCO TCS.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles